ABIVAX Société Anonyme completed the acquisition of Prosynergia.
ABIVAX Société Anonyme (ENXTPA:ABVX) completed the acquisition of Prosynergia on December 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.9 EUR | +1.26% | +2.54% | +31.36% |
05-20 | BTIG Initiates Abivax at Buy Rating With $43 Price Target | MT |
05-08 | Abivax: four abstracts to be presented on obefazimod | CF |
1st Jan change | Capi. | |
---|---|---|
+31.36% | 877M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |